The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 10,713 | 417,500 | SH | SOLE | 417,500 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 12,202 | 1,646,700 | SH | SOLE | 1,646,700 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 9,082 | 688,000 | SH | SOLE | 688,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 3,325 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,040 | 167,054 | SH | SOLE | 167,054 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 4,371 | 101,500 | SH | SOLE | 101,500 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 6,692 | 362,500 | SH | SOLE | 362,500 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,554 | 705,218 | SH | SOLE | 705,218 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,615 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 1,603 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 2,267 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 4,341 | 305,900 | SH | SOLE | 305,900 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 6,441 | 1,497,900 | SH | SOLE | 1,497,900 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 22,912 | 1,545,000 | SH | SOLE | 1,545,000 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 947 | 615,000 | SH | SOLE | 615,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 13,611 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 2,946 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,539 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,740 | 357,500 | SH | SOLE | 357,500 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 3,025 | 381,500 | SH | SOLE | 381,500 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,318 | 392,500 | SH | SOLE | 392,500 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 43,493 | 511,500 | SH | SOLE | 511,500 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 8,798 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,370 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 4,526 | 802,500 | SH | SOLE | 802,500 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 1,044 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 29,813 | 973,000 | SH | SOLE | 973,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 12,591 | 830,000 | SH | SOLE | 830,000 | 0 | 0 | ||
LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 7,616 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 12,429 | 667,500 | SH | SOLE | 667,500 | 0 | 0 | ||
PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 3,360 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 7,728 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 10,421 | 277,000 | SH | SOLE | 277,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 13,752 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 5,863 | 2,364,204 | SH | SOLE | 2,364,204 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 27,858 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
SURFACE ONCOLOGY INC | COM | 86877M209 | 7,507 | 1,088,000 | SH | SOLE | 1,088,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,553 | 240,744 | SH | SOLE | 240,744 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 12,121 | 853,000 | SH | SOLE | 853,000 | 0 | 0 | ||
UNUM THERAPEUTICS INC | COM | 903214104 | 959 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 2,904 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 913 | 107,500 | SH | SOLE | 107,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,321 | 300,000 | SH | SOLE | 300,000 | 0 | 0 |